Disc Medicine (IRON – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rami Katkhuda from LifeSci Capital maintained a Buy rating on the stock and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback